Is BAP1 p.Glu406Gly (c.1217A>G) pathogenic?

BAP1 p.Glu406Gly (c.1217A>G) is classified Uncertain significance in BAP1 (ClinVar, Multiple submitters, 3 submitters; last evaluated 2024-10-31). AlphaMissense: likely benign (0.1025); Absent from gnomAD v4.1; Associated with hereditary neoplastic syndrome.

What condition is associated with BAP1 p.Glu406Gly (c.1217A>G)?

BAP1 p.Glu406Gly (c.1217A>G) is associated with hereditary neoplastic syndrome, BAP1-related tumor predisposition syndrome (ClinVar).

How common is BAP1 p.Glu406Gly (c.1217A>G) in the general population?

BAP1 p.Glu406Gly (c.1217A>G) is absent from gnomAD v4.1 (gnomAD).

What do computational predictors say about BAP1 p.Glu406Gly (c.1217A>G)?

AlphaMissense predicts likely benign (score 0.1025) — an in-silico prediction, not a clinical call.

BAP1 p.Glu406Gly

c.1217A>G · VCV3477855

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 3 submitters

AlphaMissense

likely benign

0.1025 · ACMG-weighted

gnomAD v4.1

Absent

absent from gnomAD v4.1

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense	0.1025	likely benign
REVEL	0.071	moderately benign-leaning
SaProt	LLR -8.29	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	<0.2	all four deltas below 0.2 · T>A here scores Δ0.40 · evaluated, not missing
Constraint at this position
Conservation	phyloP 7.9	GERP 1.8, phastCons 1
Overall
CADD	22.6	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene: BAP1
Protein: p.Glu406Gly
Coding: c.1217A>G
MANE Select: NM_007212 · reported on NM_004656
Type: single nucleotide variant
Location: chr3:52404486 (GRCh38)
Structure: AlphaFold pLDDT 78.27 · 28 PDB

Full BAP1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: BAP1-related tumor predisposition syndrome

Similar variants

BAP1 p.Glu406= Likely benign ★★ same residue
BAP1 p.Glu406Ala Conflicting classifications of pathogenicity ★ ⚠ same residue
BAP1 p.Glu406Asp Conflicting classifications of pathogenicity ★ ⚠ same residue
BAP1 p.Glu406Lys Conflicting classifications of pathogenicity ★ ⚠ same residue
BAP1 p.Glu406Val Conflicting classifications of pathogenicity ★ ⚠ same residue
BAP1 p.Glu406del Conflicting classifications of pathogenicity ★ same residue
BAP1 c.1117-1G>A Likely pathogenic ★★ same condition
BAP1 c.122+1G>A Pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bap1-p-glu406gly (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown